Silverberg JI, Cork M, Wollenberg A, Katoh N, Steffensen LA, Kurbasic A, Olsen CK, Kuznetsova A, ?sterdal ML, Vilsb?ll AW, Deleuran M. Early Changes in Patient-Relevant Endpoints in Three Tralokinumab Pivotal Phase 3 Trials (ECZTRA 1−3) in Adult Patients with Moderate-to-Severe Atopic Dermatitis. J of Skin [Internet]. 2020 Oct. 27 [cited 2024 Jul. 22];4(6):s98. Available from: https://jofskin.org/33014/index.php/skin/article/view/1068